Chugai Pharmaceutical Co (TSE:4519) Dividend Payout Ratio: 0.00 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4519 Chugai Pharmaceutical Co Ltd TSE:4519
97 GF Score
Price 円7,230.00
GF Value 円7,735.19
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Chugai Pharmaceutical Co Dividend Payout Ratio?

Chugai Pharmaceutical Co TSE:4519 -2.15% 97 Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus rates TSE:4519 with a GF Score™ of 97/100 and a GF Value™ of 円7,735.19 (Fairly Valued). The stock has 1 warning sign investors should review. Among 445 Drug Manufacturers companies, Chugai Pharmaceutical Co ranks worse than 58.43% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Chugai Pharmaceutical Co's Dividend Payout Ratio for the months ended in Mar. 2026 was 0.00.

The historical rank and industry rank for Chugai Pharmaceutical Co's Dividend Payout Ratio or its related term are showing as below:

TSE:4519' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.31   Med: 0.41   Max: 0.53
Current: 0.44

During the past 13 years, the highest Dividend Payout Ratio of Chugai Pharmaceutical Co was 0.53. The lowest was 0.31. And the median was 0.41.

TSE:4519's Dividend Payout Ratio is ranked worse than
58.43% of 445 companies
in the Drug Manufacturers industry
Industry Median: 0.38 vs TSE:4519: 0.44

As of today (2026-07-14), the Dividend Yield % of Chugai Pharmaceutical Co is 1.91%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Chugai Pharmaceutical Co was 2.51%. The lowest was 0.55%. And the median was 1.30%.

Chugai Pharmaceutical Co's Dividends per Share for the months ended in Mar. 2026 was 円0.00.

During the past 12 months, Chugai Pharmaceutical Co's average Dividends Per Share Growth Rate was 24.50% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 16.10% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 16.20% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 24.40% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Chugai Pharmaceutical Co was 46.80% per year. The lowest was 0.00% per year. And the median was 10.80% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Chugai Pharmaceutical Co (TSE:4519) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Chugai Pharmaceutical Co Dividend Payout Ratio Related Terms

Chugai Pharmaceutical Co Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Chugai Pharmaceutical Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chugai Pharmaceutical Co Dividend Payout Ratio Chart

Chugai Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.40 0.40 0.40 0.42 0.45

Chugai Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.85 0.00 0.91 0.00

TSE:4519 vs LLY, JNJ, ABBV: Dividend Payout Ratio Comparison

For the Drug Manufacturers - General subindustry, Chugai Pharmaceutical Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chugai Pharmaceutical Co Dividend Payout Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chugai Pharmaceutical Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Chugai Pharmaceutical Co's Dividend Payout Ratio falls into.


TSE:4519
97GF Score
Chugai Pharmaceutical Co Ltd TSE:4519
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chugai Pharmaceutical Co Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Chugai Pharmaceutical Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2025 )/ EPS without NRI (A: Dec. 2025 )
=122/ 274.02
=0.45

Chugai Pharmaceutical Co's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2026 )/ EPS without NRI (Q: Mar. 2026 )
=0/ 70.13
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 0.00 mean?
Chugai Pharmaceutical Co (TSE:4519) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Chugai Pharmaceutical Co and its competitors. Over the past decade, Chugai Pharmaceutical Co's Dividend Payout Ratio has ranged from 0.31 to 0.53. According to the industry distribution chart, Chugai Pharmaceutical Co ranks #260 out of 445 companies in the Drug Manufacturers industry, placing it in the top 58.4%.
Is Chugai Pharmaceutical Co's Dividend Payout Ratio too high?
Chugai Pharmaceutical Co's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.31 to a high of 0.53. Based on the distribution chart, Chugai Pharmaceutical Co ranks #260 out of 445 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Chugai Pharmaceutical Co has a GF Score™ of 97/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Chugai Pharmaceutical Co's Dividend Payout Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Chugai Pharmaceutical Co ranks #260 out of 445 companies for Dividend Payout Ratio. This places Chugai Pharmaceutical Co in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. Historically, Chugai Pharmaceutical Co's own Dividend Payout Ratio has ranged from 0.31 to 0.53 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 445 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Chugai Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chugai Pharmaceutical Co's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chugai Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Chugai Pharmaceutical Co (TSE:4519) is currently considered Fairly Valued. The stock's GF Value™ is 円7,735.19, compared to a current price of 円7,230.00 — trading 6.5% below its estimated fair value. The current Dividend Payout Ratio is 0.00. Chugai Pharmaceutical Co's overall GF Score™ is 97/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Chugai Pharmaceutical Co (TSE:4519), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chugai Pharmaceutical Co (TSE:4519) Overvalued in 2026?

Based on GuruFocus' analysis, Chugai Pharmaceutical Co stock appears to be undervalued. The current stock price of 円7,230.00 is trading 6.5% below its estimated GF Value™ of 円7,735.19. GuruFocus considers Chugai Pharmaceutical Co to be Fairly Valued.

Key valuation signals for TSE:4519:

  • Dividend Payout Ratio: 0.00
  • GF Value™: 円7,735.19 vs. price of 円7,230.00 (6.5% below fair value)
  • GF Score™: 97/100 with 1 warning sign

No single metric tells the full story. See the TSE:4519 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chugai Pharmaceutical Co Business Description

Address 2-1-1 Muromachi, Nihonbashi, 12th Floor, Nihonbashi Mitsui Tower, Chuo-ku, Tokyo, JPN, 103-8324
Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra (hemophilia), Actemra (rheumatoid arthritis, covid), Foundayo (oral obesity pill), and Nemluvio (atopic dermatitis, prurigo nodularis).
97GF Score

Get the complete analysis for TSE:4519

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円7,230.00
Price
円7,735.19
GF Value